ポリコーム群遺伝子Pcgf5の造血幹・前駆細胞における機能解析 by SI, Sha & 司, 沙
  
 
 
Functional analysis of the polycomb-group gene Pcgf5 in 
hematopoietic stem and progenitor cells 
 
 
（ポリコーム群遺伝子Pcgf5の造血幹・前駆細胞における機
能解析） 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
千葉大学大学院医学薬学府 
先端医学薬学専攻 
（主任：岩間 厚志教授） 
司 沙 
 
 
 
Abstract  
Polycomb-group RING finger proteins (Pcgf1-Pcgf6) are components of Polycomb 
repressive complex 1 (PRC1)-related complexes that catalyze monoubiquitination of 
histone H2A at lysine 119 (H2AK119ub1), an epigenetic mark associated with repression 
of genes. Pcgf5 has been characterized as a component of PRC1.5, one of the non-
canonical PRC1, consisting of Ring1a/b, Rybp/Yaf2 and Auts2. However, the biological  
functions of Pcgf5 have not yet been identified. Here we analyzed the impact of the 
deletion of Pcgf5 specifically in hematopoietic stem and progenitor cells (HSPCs). Pcgf5 
is expressed preferentially in hematopoietic stem cells (HSCs) and multipotent 
progenitors (MPPs) compared with committed myeloid progenitors and differentiated 
cells. We transplanted bone marrow (BM) cells from Rosa::Cre-ERT control and Cre-
ERT;Pcgf5fl/fl mice into lethally irradiated recipient mice. At 4 weeks post-transplantation, 
we deleted Pcgf5 by injecting tamoxifen, however, no obvious changes in hematopoiesis 
was detected including the number of HSPCs during a long-term observation period 
following the deletion. Competitive BM repopulating assays revealed normal 
repopulating capacity of Pcgf5-deficient HSCs. Nevertheless, Pcgf5-deficient HSPCs 
showed a significant reduction in H2AK119ub1 levels compared with the control. ChIP-
sequence analysis confirmed the reduction in H2AK119ub1 levels, but revealed no 
significant association of changes in H2AK119ub1 levels with gene expression levels. 
Our findings demonstrate that Pcgf5-containing PRC1 functions as a histone modifier in 
vivo, but its role in HSPCs is limited and can be compensated by other PRC1-related 
complexes in HSPCs. 
 
  
Introduction 
Epigenetic regulation has a critical role not only in normal hematopoiesis but also in 
hematological malignancies [1-3]. Polycomb-group (PcG) proteins are key regulators of 
the epigenetic machinery that establish and maintain reversible gene silencing. PcG 
proteins form various polycomb repressive complexes (PRC). The PRC1 and PRC2 
complexes possess H2AK119 ubiquitin ligase activity and H3K27 methyltransferase 
activity, respectively. Six PRC1-related complexes containing distinct Polycomb-group 
RING finger proteins (Pcgf1-Pcgf6) have been identified [4,5].  
  PcG complexes have been well characterized as general regulators of stem cells [6,7]. 
Pcgf4/Bmi1, a component of canonical PRC1 (PRC1.4), plays a central role in the 
maintenance of self-renewal and multipotency of hematopoietic stem cells (HSCs) by 
targeting p16Ink4a and p19Arf tumor suppressor genes and developmental regulator genes 
[8-10]. PRC2 complex has a well-established role in the maintenance of HSCs [11,12]. 
In addition to their role in stem cells, PcG proteins also function in tumor-initiating cells, 
where they are often deregulated, leading to the promotion of tumorigenesis. Thus, PcG 
genes act as both oncogenes as well as tumor suppressor genes depending on cell type [3, 
13-15].  
  PRC1.5 is one of the emerging variant PRC1 complexes, and consists of Ring1a/b, 
Pcgf5, Rybp/Yaf2 and Auts2. Pcgf5 and Auts2 are components unique to PRC1.5. Of 
interest, Auts2 has been shown to render PRC1 capable of activating transcription by 
recruiting casein kinase 2 and p300 in developing neuronal cells [16]. In contrast, Pcgf5 
has been demonstrated to contribute to H2AK119ub1-dependent recruitment of PRC2 
and H3K27me3 modification in a manner similar to other variant PRC1 complexes, Pcgf1 
and Pcgf3, in a de novo targeting assay in mouse embryonic stem cells (ESCs) [17]. 
However, its role in vivo remains to be investigated.  
  In this study, we analyzed the role of Pcgf5 in hematopoietic stem and progenitor cells 
(HSPCs). Using a Pcgf5 conditional knockout mouse model and comprehensive 
expression and epigenetic analyses, we demonstrate that Pcgf5 regulates global H2A 
monoubiquitylation but is dispensable for hematopoietic stem and progenitor cells. 
 
  
Materials and Methods 
Ethics Statement 
Experiments using mice were performed in accordance with institutional guidelines of 
the Graduate School of Medicine, Chiba University. This study was approved by the 
Institutional Review Committees of Chiba University (approval numbers 24-64 and 27-
213).  
 
Mice and gene targeting of Pcgf5  
The conditional Pcgf5 allele (Pcgf5fl), which contains LoxP sites flanking Pcgf5 exon 2 
containing the first ATG, was generated by homologous recombination using R1 
embryonic stem (ES) cells according to the conventional protocol. Pcgf5fl/+ mice were 
backcrossed to the C57BL/6 background more than 5 times and crossed with Rosa::Cre-
ERT2 mice (TaconicArtemis GmbH). To induce Cre activity, mice were injected with 100 
μl of tamoxifen dissolved in corn oil at a concentration of 10 mg/ml intraperitoneally once 
a day for 5 consecutive days 1 month after transplantation. C57BL/6 mice congenic for 
the Ly5 locus (CD45.1) were purchased from Sankyo Lab Service.  
 
Locus-specific genotyping of Pcgf5 
We performed genotyping of Pcgf5 allele using the following primers.  
5’-GACCCTGAAGGAGTTGGCTCG-3’ and 5’- TGGCCTTGGTACACATATAGC-3’ 
for flox allele, and 5’-TGTTTACAGAGAGGAAGCGCC-3’ and 5’-
TGGCCTTGGTACACATATAGC-3’ for delta allele.  
 
Bone marrow transplantation 
Bone marrow (BM) cells from test mice (CD45.2) were injected via the tail veins of 8-
week-old CD45.1 recipients lethally irradiated at a dose of 9.5 Gy with or without 
competitor BM cells from 8-week-old CD45.1 congenic mice. For secondary 
transplantation, 5 × 106 BM cells pooled from the primary recipient mice at 4 months 
post-transplantation were injected into 8-week-old CD45.1 mice (secondary recipient 
mice) irradiated at a dose of 9.5 Gy without competitor cells.  
 
Purification of hematopoietic cells and flow cytometric analysis 
BM mononuclear cells were incubated with APC-conjugated anti-c-Kit antibody 
followed by anti-APC MicroBeads (Miltenyi Biotec). c-Kit+ cells were 
immunomagnetically enriched by passing through an LS column (Miltenyi Biotec).  
Purified c-Kit+ cells were then stained with a mixture of biotin-conjugated mAbs against 
lineage markers, including Gr-1, Mac-1, interleukin (IL)-7Rα, B220, CD4, CD8, and 
Ter119, and FITC-conjugated anti-CD34, PE-conjugated anti-FcRII/III, PE-Cy7-
conjugated anti-Sca-1, and APC-conjugated anti-c-Kit antibodies. Biotinylated 
antibodies were detected with APC-Cy7-conjugated streptavidin. CD45.1 and CD45.2 
antibodies were used as additional markers for recipient cells and donor-derived cells, 
respectively. Flow cytometric analyses were performed using antibodies recognizing the 
following antigens: CD45.2 (104), CD45.1(A20), Gr-1 (RB6-8C5), CD11b/Mac-1 
(M1/70), Ter-119, CD127/IL-7R (A7R34, SB/199), B220 (RA3-6B2), CD4 (GK1.5, 
RM4-5), CD8 (53–6.7), CD117/c-Kit (2B8), Sca-1 (D7), CD135 (A2F10) and 
CD16/32/FcRII-III (93). The antibodies were purchased from BD Biosciences, 
eBioscience, and BioLegend. Dead cells were eliminated by staining with 0.5 μg/ml 
propidium iodide (Sigma-Aldrich). The data were acquired on a FACS Aria II cell sorter 
or a Canto II flow cytometer (both BD Biosciences), and analyzed using Flowjo Version 
10.0.6 software (TreeStar). 
 
Chromatin immunoprecipitation (ChIP) assay and ChIP-Sequence analysis 
FACS-sorted GMPs from the BM of recipient mice were cross-linked with 0.5% 
formaldehyde for 2 minutes at 37°C, washed twice with phosphate-buffered saline, 
suspended in ChIP buffer (10 mM Tris-HCl, pH 8.0, 200 mM NaCl, 1 mM CaCl2, 0.5% 
NP-40, and protease inhibitor cocktail), sonicated 3 times for 5 seconds using Bioruptor 
(Cosmo Bio), digested by MNase (New England BioLabs) for 40 minutes at 37°C, lysed 
with radioimmunoprecipitation assay (RIPA) buffer (50mM Tris-HCl, pH 8.0, 150 mM 
NaCl, 2 mM EDTA, 1% NP-40, 0.1% SDS and 0.5% sodium deoxycholate) and then 
sonicated 10 times for 5 seconds using Bioruptor (Cosmo Bio). Dynabeads M-280 Sheep 
anti-Rabbit IgG (Life technologies) blocked with bovine serum albumin was used for 
collection of chromatin. Before the immunoprecipitation, 20 l of Dynabeads was 
incubated with an anti–H3K27me3 antibody (07-449; Millipore) or an anti–
monoubiquitinated H2A (H2Aub1; 8240S, Cell Signaling Technology) for 2 hours at 4°C. 
Chromatin was immunoprecipitated overnight at 4°C with antibody-conjugated 
Dynabeads. The immunoprecipitates were washed extensively with the following 
combination of wash buffers: ChIP buffer, ChIP wash buffer (10 mM Tris-HCl, pH 8.0, 
500 mM NaCl, 1 mM CaCl2, 0.5% NP-40), and TE buffer (10 mM Tris-HCl, pH 8.0, and 
1 mM EDTA). Bound chromatin and input DNA were placed in ChIP elution buffer (50 
mM Tris-HCl, pH 8.0, 10 mM EDTA and 1% SDS) and reverse cross-linked. 
Immunoprecipitated DNA and input DNA were treated with RNase A (Sigma-Aldrich) 
and proteinase K (Roche), and purified with a QIAquick PCR purification kit (Qiagen). 
Libraries for ChIP-sequene were generated using ThruPLEX DNA-seq Kit (Rubicon 
genomics). 
 
RNA-sequence  
Total RNA isolation was performed using an RNeasy plus Micro Kit (Qiagen) according 
to the manufacturer’s instructions. cDNA was synthesized using a SMARTer Ultra Low 
Input RNA Kit for Sequencing (Clontech). cDNA libraries were generated with 6x103 
LSK cells and GMPs using a NEBNext Ultra DNA Library Prep Kit (New England 
BioLabs) according to the manufacturer’s indications. The RNA-sequence reads were 
aligned using TopHat 1 (version 2.0.13; with default parameters) and levels of gene 
expression were quantified using Cufflinks (version 2.2.1).  
 
RT-qPCR.  
Total RNA was isolated using TRIZOL LS solution (Invitrogen) and reverse-transcribed 
by the ThermoScript RT-PCR system (Invitrogen) with an oligo-dT primer. Quantitative 
RT-PCR (RT-qPCR) was performed with a StepOnePlus Real-Time PCR System (Life 
Technologies) using FastStart Universal Probe Master (Roche) and the indicated 
combinations of Universal Probe Library (Roche) and primers listed below. Hprt 
expression was used to calculate relative expression levels. Probe numbers and primer 
sequences were: Probe #26, 5’-AGATGGCGACTAAGAG GAGAAA-3’ and 5’-
ACAAATAGTGCAGGATTCATTCAG-3’ for Pcgf5; and probe #95, 5’-
TCCTCCTCAGACCGCTTTT-3’ and 5’- CCTGGTTCATCATCGCTAATC-3’ for Hprt. 
To amplify truncated Pcgf5 mRNA, primers directed to exon 1 and exon 5/6 junction 
were used: 5’-GGCGCTGTTTCTCTTTCGC-3’ for exon 1 and 5’-
CTTCGAAATATCATCTTGCCC-3’ for exon 5/6 junction. 
 
Immunoprecipitation and Western blot analysis for histone modification 
Pcgf5fl/fl;Rosa::Cre-ERT2 ES cells were derived from blastocysts. Conditional deletion 
of Pcgf5 was carried out by the addition of 800 nM 4-hydroxytamoxifen for 48 h in 
culture. For collection, ES cells were trypsinized and plated to gelatin-coated dishes for 
30 min to remove contaminating feeder cells. The cells were lysed in 0.1% NP-40 lysis 
buffer (300 mM NaCl) and centrifuged. The resulting supernatants were kept on ice 
(Solution A). The pellets were resuspended in 0.1% NP-40 lysis buffer (300 mM NaCl) 
and sonicated using a Bioruptor (Cosmo Bio) (Solution B). The mixtures of Solution A 
and Solution B were diluted with 0.1% NP-40 lysis buffer (0 mM NaCl) until the final 
NaCl concentrations reached 150 mM. After centrifugation, the resulting 
supernatants were used as input lysates for immunoprecipitation, which was 
performed using an anti-Ring1b antibody (D139-3, MBL). Total lysates were used to 
detect histone proteins. Proteins were separated by SDS-PAGE, transferred to a PVDF 
membrane and detected by Western blotting using the following antibodies: anti-Pcgf5 
antibody (ab76724, Abcam), anti-H3 (ab1791, Abcam), anti-H3K27me3 (07-449, 
Millipore), anti-H2A (ab18255, Abcam), and anti-H2AK119ub (8240S, Cell Signaling 
Technology). The protein bands were detected with enhanced chemiluminescence reagent 
(Immobilon Western, Millipore). Sequential reprobing of membranes with antibodies was 
performed after the removal of primary and secondary antibodies from membranes in 
0.2M glycine-HCl buffer (pH 2.5) and/or inactivation of HRP by 0.1% NaN3. 
 
Statistical analysis 
Statistical tests were carried out using Graph Pad Prism version 6. Data are shown as the 
mean ± SD. Statistical significance was taken at values of *p less than .05, ** p less 
than .01, and *** p less than .001. 
 
Accession numbers  
RNA-sequence and ChIP-sequence data were deposited in DNA Data Bank of Japan 
(DDBJ) (accession number DRA004231).  
 
  
Results 
Pcgf5 is preferentially expressed in hematopoietic stem and progenitor cells 
We first analyzed the expression of Pcgf5 in hematopoietic cells by RT-PCR. Pcgf5 
appeared to be preferentially expressed in CD34- Flt3- Lineage marker- Sca-1+ c-Kit+ 
(CD34-LSK) long-term (LT)-HSCs, CD34+Flt3-LSK short-term (ST)-HSCs and 
CD34+Flt3+LSK multipotent progenitor cells (MPPs), but downregulated during 
differentiation (Fig 1A). To understand the role of Pcgf5 in hematopoietic stem and 
progenitor cells (HSPCs), we generated mice harboring Pcgf5fl allele in which exon 2 
containing the first ATG is floxed (Fig 1B) and then crossed Pcgf5fl/fl mice with 
Rosa26::Cre-ERT (Cre-ERT) mice to generate Cre-ERT;Pcgf5fl/fl mice.  
  To exclude any influences of the loss of Pcgf5 on organs other than hematopoietic 
system, we transplanted BM cells from Cre-ERT control and Cre-ERT;Pcgf5fl/fl mice with 
and without competitor cells into lethally irradiated recipient mice (CD45.1) and deleted 
Pcgf5 by intraperitoneal injection of tamoxifen at 1 month post-transplantation (Fig 1C). 
We confirmed the efficient deletion of Pcgf5 by genomic PCR of CD45.2 donor cells in 
the PB (Fig 1D). We also confirmed the generation of a short form of Pcgf5 mRNA 
lacking exon 2 in BM Lineage marker- c-Kit+ (LK) progenitor cells after injection of 
tamoxifen (Fig 1E). Pcgf5 functions as a component of PRC1.5. In order to examine 
whether the functional Pcgf5 proteins are translated from the internal ATG of the short 
form of Pcgf5 mRNA, we prepared lysates from Pcgf5fl/fl and Pcgf5Δ/Δ ES cells, and 
immunoprecipitated Ring1b. Pcgf5 was readily detected in the immunoprecipitates from 
Pcgf5fl/fl cells, but not Pcgf5Δ/Δ cells. Even the short form of Pcgf5 was not detected in 
immunoprecipitates from Pcgf5Δ/Δ ES cells. These results indicate that no functional 
Pcgf5 protein that can bind Ring1b is translated from the truncated Pcgf5 mRNA lacking 
the first ATG (Fig 1F). The level of Ring1b protein did not largely change in Pcgf5Δ/Δ 
hematopoietic cells and ES cells (data not shown). 
 
Deletion of Pcgf5 in adult hematopoietic cells does not compromise hematopoiesis 
In order to evaluate the role of Pcgf5 in HSPCs, we first transplanted BM cells from Cre-
ERT control and Cre-ERT;Pcgf5fl/fl mice without competitor cells into lethally irradiated 
recipient mice. After the deletion of Pcgf5, PB cell counts showed moderate reduction in 
white blood cell (WBC) counts in Pcgf5Δ/Δ mice, although it did not reach statistical 
significant levels (Fig 2A). RBC counts, hemoglobin content and platelet counts did not 
significantly change in the absence of Pcgf5 (Fig 2A). In addition, no obvious change of 
lineage contribution of donor cells to PB hematopoietic cells was detected after the 
deletion of Pcgf5 (Fig 2B). Correspondingly, BM analysis at 4 months post-deletion of 
Pcgf5 revealed no significant changes in the number of total BM cells (Fig 2C), LSK 
HSPCs, common lymphoid progenitors (CLPs) and myeloid progenitors including 
common myeloid progenitors (CMPs), granulocyte-macrophage progenitors (GMPs), 
and megakaryocyte-erythroid progenitors (MEPs) (Fig 2D).  
  We next explored the consequences of Pcgf5 loss on the competitive repopulating 
capacity of HSPCs. We transplanted BM cells from Cre-ERT control and Cre-
ERT;Pcgf5fl/fl mice with the same number of competitor cells from CD45.1 congenic 
wild-type (WT) mice into lethally irradiated recipient mice. Even in this competitive 
setting, no evident changes were detected in chimerism of CD45.2+ Pcgf5Δ/Δ cells in the 
PB compared with the control (Fig 3A). BM analysis at 3 months post-deletion of Pcgf5 
revealed a mild but significant increase in the chimerism of CD45.2+ Pcgf5Δ/Δ cells in total 
cells, LSK HSPCs, CLPs, and myeloid progenitors in the BM (Fig 3B), but not in splenic 
LSK cells nor total thymocytes in the thymus (Fig 3C). To further evaluate the 
repopulating capacity of Pcgf5Δ/Δ HSPCs, we analyzed BM from secondary recipients 
transplanted with pooled BM cells from primary mice. Chimerism of Pcgf5Δ/Δ cells was 
comparable to WT cells in both PB and BM of secondary recipients (Figs 3D and E). The 
trend of Pcgf5Δ/Δ HSPCs toward higher chimerism in the BM of primary mice totally 
disappeared in the secondary recipients. These results suggest that the loss of Pcgf5 does 
not significantly alter reconstitution capacity of HSPCs. 
 
Loss of Pcgf5 has a limited effect on the transcriptional profiles of HSPCs 
To understand the effects of Pcgf5 loss on HSPCs, we next purified LSK HSPCs and 
GMPs from BM at 4 months post-deletion of Pcgf5 and performed RNA-sequence 
analysis. RNA-sequence data confirmed the absence of Pcgf5 transcript corresponding to 
exon 2 deleted in Pcgf5Δ/Δ cells (Fig 4A). The number of genes altered greater than 2-fold 
in the absence of Pcgf5 was relatively small (Fig 4B) and the expression changes were 
mild (Fig 4B). Indeed, the levels of expression changes in Pcgf5Δ/Δ cells were not 
statistically significant compared with WT cells (Fig 4C). Genes upregulated greater that 
2-fold in Pcgf5Δ/Δ LSK cells significantly overlapped with those in Ezh2Δ/Δ LSK cells [18], 
but, of interest, barely with those in Pcgf4/Bmi1Δ/Δ LSK cells [19] (Fig 4D). Given the 
minimal hematological phenotypes in the absence of Pcgf5, we assumed that the other 
Pcgf family genes were activated to complement Pcgf5 loss. However, RNA-seq data did 
not show activation of any other family genes in the absence of Pcgf5 (Fig 4E). 
Nevertheless, RNA-sequence data revealed that the expression of Pcgf1 and Pcgf5 in 
Reads Per Kilobase of exon per Million mapped fragments (RPKM) was much higher 
than the other member genes in LSK cells and GMPs (Fig 4E), suggesting that Pcgf1 and 
Pcgf5 are the major Pcgf family genes expressed in HSPCs. 
 
Global levels of H2AK119ub1 are significantly reduced in the absence of Pcgf5 
As shown in Figure 1F, Pcgf5 functions as a component of PRC1-related complex. As 
expected from these data, global H2AK119ub1 level was decreased by 40% in Pcgf5Δ/Δ 
Lin-c-Kit+ progenitor cells in Western blot analysis, while H3K27 level was not altered 
in the absence of Pcgf5 (Fig 5A).  
  We next performed ChIP-sequence analysis of H2AK119ub1 and H3K27me3 in GMPs 
from recipient mice at 4 months post-deletion of Pcgf5. We defined genes with  2-fold 
enrichment of H2AK119ub1 ChIP signals over the input signals at the promoter region 
(2.0 kb  transcriptional start sites) as H2AK119ub1 genes (Fig 5B). H2AK119ub1 genes 
in WT GMPs significantly overlapped with genes marked with H2AK119ub1 in ES cells 
[20] (Fig 5C). Importantly, nearly 20 % of H2AK119ub1 genes showed reduction in 
H2AK119ub1 levels  2-fold upon loss of Pcgf5 in GMPs (Figs 5B and C). Indeed, 
H2AK119ub1 ChIP signals over the input signals were significantly reduced in Pcgf5Δ/Δ 
GMPs compared with WT GMPs, while those of H3K27me3 showed a very mild albeit 
significant increase in Pcgf5Δ/Δ GMPs (Figs 5D). Polycomb-related histone marks, 
H2AK119ub1 and H3K27me3, mutually reinforce each other and behave in a similar 
manner in many settings. Unexpectedly, however, H2AK119ub1 genes that showed 
reduction in H2AK119ub1 levels  2-fold in Pcgf5Δ/Δ GMPs (Pcgf5Δ/Δ_Down genes) 
showed a significant increase in H3K27me3 levels (Fig 5D). In contrast to our expectation, 
comparison of ChIP signals with expression changes revealed no significant correlation 
of reduced H2AK119ub1 levels with gene expression (Figs 5E and F). Moreover, 
Pcgf5Δ/Δ_Down genes (listed in gene symbol) little overlapped with genes upregulated 
greater than 2-fold in Pcgf5Δ/Δ GMPs relative to WT GMPs (Pcgf5Δ/Δ 
GMPs_Exp_Up)(Figure 5G). These findings well correspond to the mild changes in 
global gene expression and minimal hematological phenotypes in Pcgf5Δ/Δ HSPCs. 
  In order to understand the minimal effect of the loss of Pcgf5 in gene expression, we 
overexpressed 3xFlag-Pcgf1 and 3xFlag-Pcgf5 in mouse erythroleukemia (MEL) cells 
and performed ChIP-sequence analysis of Pcgf1, Pcgf5 and H2K119ub1. We found that 
Pcgf1 regulates more gene promoters (2.0 kb  transcriptional start sites) than Pcgf5 and 
also bound most of the Pcgf5 targets (82.1%). Among Pcgf5 targets, Pcgf1 regulated the 
majority of Pcgf5 targets associated with the H2AK119ub1 modification (89.3%) in MEL 
cells. (Fig 5H and Table 1). These findings suggest that Pcgf1 largely compensates for the 
loss of Pcgf5.  
Discussion 
In this study, we generated Pcgf5 conditional knockout mice and found that the 
hematopoietic-specific deletion of Pcgf5 results in no significant changes in 
hematopoiesis compared with control mice. However, Pcgf5 appeared to contribute to the 
global monoubiqutination of H2AK119 in hematopoietic cells. Although the absence of 
Pcgf5 did not greatly affect the gene expression profiles of HSPCs, our findings provide 
the first direct evidence that supports PRC1-related function of Pcgf5 that is involved in 
the regulation of H2AK119ub1.  
  Pcgf5 has repeatedly been identified as a component of variant PRC1 that include 
Auts2 (PRC1.5). As other Pcgf family proteins, Pcgf5 has been thought to support the 
monoubiquitination of H2AK119 by Ring1b, however, this has never been conformed in 
vivo. In this study, Pcgf5-deficient HSPCs clearly showed reduction in H2AK119ub1 
levels. Nearly 20 % of gene promoters (1,147 genes) marked with H2AK119ub1 in WT 
GMPs reduced H2AK119ub1 levels greater that 2-fold in GMPs in the absence of Pcgf5. 
This finding suggests that Pcgf5 targets a large number of genes and plays a major role 
in the regulation of H2AK119ub1. Upregulated genes in Pcgf5-deficient LSK cells 
significantly overlapped with those in Ezh2-deficient LSK cells, suggesting that Pcgf5 
targets largely overlap with those of PRC2. In contrast, however, upregulated genes in 
Pcgf5-deficient LSK cells did not significantly overlap with those in Pcgf4/Bmi1-
deficient LSK cells, suggesting that Pcgf5 in variant PRC1 regulates genes distinct from 
those of canonical PRC1 that contains Pcgf4/Bmi1 in HSPCs. Recently, Pcgf2/Mel18-
containing PRC1 complexes have been reported to exchange subunits in a stage-specific 
manner during cardiac differentiation and regulate both transcriptional repression and 
activation of distinctive sets of target genes [21]. Because more genes were 
downregulated upon Pcgf5 deletion, Pcgf5 could function like Pcgf2/Mel18 in a context-
specific manner. 
  As described above, Pcgf5 as well as Pcgf1 and Pcgf3, has been shown to recruit PRC2 
in an H2AK119ub1-dependent manner and induce H3K27me3 modification at its target 
genes in a de novo targeting assay in mouse ESCs [17]. Therefore, we expected to see a 
reduction in H3K27me3 levels at the Pcgf5 target genes. However, H2AK119ub1 genes 
that showed reduction in H2AK119ub1 levels ( 2-fold) in Pcgf5Δ/Δ GMPs 
(Pcgf5Δ/Δ_Down genes) displayed rather increased H3K27me3 levels at their promoters. 
Although the molecular mechanism underlying this epigenomic alteration remains 
unclear, it is possible that several different pathways that recruit polycomb complexes 
exist as backup, and some of them could be activated in a setting of polycomb dysfunction. 
In the case of Pcgf5 loss, we identified augmentation in H3K27me3 levels, which might 
represent activation of the compensatory pathway and could be responsible for the 
maintenance of transcriptional repression of the Pcgf5Δ/Δ_down genes in HSPCs.    
  Pcgf5 expression is high in HSPCs compared with differentiated cells and appeared to 
be the major Pcgf family gene expressed in HSPCs. RNA-sequence data demonstrated 
that Pcgf1 and Pcgf5 are most abundant in HSPCs. However, the impact of loss of Pcgf5 
was very limited in HSPCs. These findings suggest that Pcgf5 function could be 
compensated by other family members such as Pcgf1, which is highly expressed in 
HSPCs. Pcgf1 is the component of the non-canonical PRC1 complex, PRC1.1, and has 
been demonstrated to cause a drastic reduction in H2AK119ub1 levels in murine ESCs 
upon knockdown [22]. Indeed, ChIP-sequence analysis in MEL cells demonstrated that 
Pcgf5 targets are mostly co-regulated by Pcgf1. Given that the loss of Pcgf5 was largely 
compensated for in HSPCs, the role of Pcgf1-containing PRC1.1 could be more critical 
than Pcgf5-containing PRC1.5 in the maintenance of HSPCs. Further study of non-
canonical PRC1 complexes is needed to decipher their physiological functions in HSPCs. 
  Although Pcgf5 appears to be dispensable for hematopoiesis, Pcgf family gene 
expression could vary in different organs and tissues and Pcgf5 may be required for the 
proliferation, survival and function of certain types of cells. The mice that harbor floxed 
allele for Pcgf5 generated in this study should serve as a valuable tool to analyze the role 
of Pcgf5 in those cells. 
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Figure legends 
 
Figure 1. Generation of conditional knockout allele for Pcgf5 in mice 
(A) RT-PCR analysis of Pcgf5 in BM hematopoietic cell fractions. Cells analyzed were 
CD34-LSK long-term HSCs, CD34+Flt3-LSK short-term HSCs, CD34+Flt3+LSK 
multipotent progenitors (MPPs), common myeloid progenitors (CMPs), granulocyte-
macrophage progenitors (GMPs), megakaryocyte-erythroid progenitors (MEPs), and 
lineage marker+ mature hematopoietic cells. Hypoxanthine-guanosine phosphoribosyl 
transferase (Hprt) was used as a housekeeping control gene. Data are shown as the mean 
± standard deviation (SD) for triplicate analyses. (B) Strategy for making a conditional 
knockout allele for Pcgf5 by homologous recombination in ES cells. FRT recombinase 
was used to remove the Neo cassette. (C) Scheme of the hematopoietic repopulation assay. 
Total BM cells (5x106 cells) from Cre-ERT and Cre-ERT;Pcgf5fl/fl were transplanted into 
lethally irradiated CD45.1 recipient mice without competitor BM cells, or 2x106 total BM 
cells were transplanted with the same number of competitor BM cells.  To induce 
deletion of Pcgf5, 100 μl of tamoxifen (10 mg/ml) was intraperitoneally injected once a 
day for five consecutive days at 1 month post-transplantation. (D) Efficient deletion of 
Pcgf5 in hematopoietic cells detected by genomic PCR. Deletion of Pcgf5 in Cre-
ERT;Pcgf5fl/fl PB myeloid cells was evaluated pre- and post-tamoxifen 
treatment. “WT”, “Floxed”, and “” alleles indicate the wild-type and floxed Pcgf5 
allele, and floxed Pcgf5 allele after removal of exon 2 by Cre recombinase, respectively. 
(E) Detection of truncated Pcgf5 mRNA in BM Pcgf5Δ/Δ LK cells using primers directed 
to exons 1 and exon 5/6 junction. (F) Pcgf5 interacts with Ring1B. Ring1B in lysates 
from Pcgf5fl/fl and Pcgf5Δ/Δ ES cells was immunoprecipitated using anti-Ring1b antibody, 
and then immunoprecipitates were detected by immunoblotting using anti-Ring1b and 
anti-Pcgf5 antibodies.  
 
Figure 2. Depletion of Pcgf5 does not compromise adult hematopoiesis  
(A) PB cell counts of recipients repopulated with Cre-ERT (+/+) and Cre-ERT;Pcgf5fl/fl 
BM cells after deletion of Pcgf5 (Δ/Δ) by tamoxifen injection. Data are shown as mean ± 
SD (n=4-5). (B) Lineage contribution of donor cells to myeloid (Gr-1+ and/or Mac-1+), B 
(B220+), or T (CD4+ and/or CD8+) cells in the PB shown as mean ± SD (n=4-5). (C) 
Absolute number of CD45.2+ donor-derived hematopoietic cells in a unilateral pair of 
femur and tibia of recipients at 5 months post-transplantation. Data are shown as mean ± 
SD (WT, n=5; Pcgf5Δ/Δ, n=6). (D) Absolute number of CD45.2+ donor-derived LSK cells, 
CLPs and myeloid progenitors in the BM of recipient mice at 5 months post-
transplantation presented as mean ± SD (WT, n=5; Pcgf5Δ/Δ, n=6). n.s., not significant.  
 
Figure 3. Pcgf5-deficient HSPCs retain normal reconstitution capacity of 
hematopoiesis 
(A) Chimerism of donor-derived cells in recipients in competitive reconstitution assays 
using the same number of test cells (Cre-ERT and Cre-ERT;Pcgf5fl/fl) and competitor cells. 
After engraftment, Pcgf5 was deleted (Pcgf5Δ/Δ) by tamoxifen injection. Data are shown 
as mean ± SD (n=4-5). (B) Chimerism of donor-derived CD45.2+ hematopoietic cells in 
total BM cells, LSK cells, CLPs and myeloid progenitor fractions at 4 months post-
transplantation. The data are shown as mean ± SD (n=7). (C) Chimerism of donor-derived 
CD45.2+ cells in splenic LSK cells and donor-derived CD45.2+ thymocytes in the thymus 
at 4 months post-transplantation shown as mean ± SD (n=3). (D, E) Secondary 
transplantation assays. Total BM cells (5x106) from primary recipient mice at 4 months 
post-transplantation were transplanted into lethally irradiated secondary recipient mice 
without competitor cells. Chimerism of donor-derived cells in the PB (D) and total 
CD45.2+ hematopoietic cells and LSK cells in the BM (E) at 5 months post-
transplantation are shown as mean ± SD (WT, n=4; Pcgf5Δ/Δ, n=5). *p<0.05; n.s., not 
significant.  
 
Figure 4. Gene expression profile of Pcgf5-deficient HSPCs 
(A) Snapshots of RNA-sequence signals at the Pcgf5 gene locus in WT and Pcgf5Δ/Δ LSK 
cells isolated from recipient mice repopulated with Pcgf5Δ/Δ hematopoietic cells. The 
structure of Pcgf5 gene locus including relevant exons is indicated at the bottom. (B) 
Scatter diagrams showing RNA-sequence data of LSK cells and GMPs. Expression levels 
of RefSeq genes (listed in RefSeq ID) defined by reads per kilobase of exon per million 
fragments mapped (RPKM) in log2 in WT and Pcgf5Δ/Δ cells are plotted. The light gray 
lines represent the boundaries for twofold increase and twofold decrease, respectively. 
The number of genes upregulated and downregulated more than twofold in Pcgf5Δ/Δ cells 
compared with WT cells are indicated in red and blue, respectively. (C) Box-and-whisker 
plots showing the expression levels of WT and Pcgf5Δ/Δ LSK cells and GMPs in RPKM. 
Boxes represent 25-75 percentile ranges. Vertical lines represent 10-90 percentile ranges. 
Horizontal bars represent medians. n.s., not significant.  (D) Venn diagram showing the 
overlap between genes (listed in gene symbol) up-regulated in LSK cells 
from Pcgf5Δ/Δ, Ezh2Δ/Δ [18], and Bmi1 KO [19] mice (≥2.0-fold compared with the WT 
control, respectively). The numbers of genes in each group are indicated. The statistical 
significance of the overlaps between the two gene groups is indicated. (E) Expression of 
Pcgf genes in WT LSK cells and GMPs in RPKM. 
 
Figure 5. Loss of Pcgf5 results in reduction in global H2AK119 levels 
(A) H2AK119ub1 levels in LK cells. LK cells from BM of WT and Pcgf5Δ/Δ mice were 
analyzed by Western blotting using anti-H2AK119ub1 and anti-H3K27me3 antibodies at 
1-month post deletion of Pcgf5. Levels of H2AK119ub1 and H3K27me3 were 
normalized to the amount of H2A and H3, respectively, and are indicated relative to wild-
type control values at the bottom. The representative data from two independent 
experiments are presented. (B) Scatter plots showing the correlation of the fold 
enrichment values against the input signals (ChIP/input) (transcription start site ± 2.0 kb) 
of H2AK119ub1 and H3K27me3 of RefSeq genes (listed in RefSeq ID) between WT 
and Pcgf5Δ/Δ GMPs. The light gray lines represent the boundaries for twofold increase and 
twofold decrease, respectively. The changes of H2AK119ub1 or H3K27me3 levels in 
genes upregulated and downregulated more than twofold in Pcgf5Δ/Δ cells compared with 
WT cells are indicated in blue and red, respectively. (C) Venn diagram showing the 
overlap between H2AK119ub1 genes (listed in gene symbol) in GMPs and ES cells. 
Pcgf5Δ/Δ _Down genes are also depicted. (D) Box-and-whisker plots showing 
H2AK119ub1 and H3K27me3 levels in all Refseq genes (All genes) and H2AK119ub1 
genes (genes with  2-fold enrichment of H2AK119ub1 ChIP signals over the input 
signals at 2.0 kb  TSSs in WT GMPs) which showed reduction in H2AK119ub1 levels 
 2-fold in Pcgf5Δ/Δ GMPs (Pcgf5Δ/Δ_Down genes).  ***p <0.001 (Student t test). (E) 
Scatter plots showing the correlation of the fold expression and fold enrichment of 
H2AK119ub1 ChIP signals in Pcgf5Δ/Δ GMPs compared with those in WT GMPs. The 
genes showing reduction in H2AK119ub1 levels greater than 2-fold (below dotted line) 
are indicated in red dots. The score of correlation coefficient between the fold expression 
and fold enrichment of H2AK119ub1 ChIP signals defined with Pearson’s correlation and 
the linear regression are shown. (F) Box-and-whisker plots showing the expression levels 
of all RefSeq genes, H2AK119ub1 genes, and Pcgf5Δ/Δ_Down genes in WT and Pcgf5Δ/Δ 
GMPs in RPKM. Boxes represent 25-75 percentile ranges. Vertical lines represent 10-90 
percentile ranges. Horizontal bars represent medians. n.s., not significant. (G) Venn 
diagram showing the overlap between Pcgf5Δ/Δ_Down genes (listed in gene symbol) in 
GMPs and genes upregulated in expression greater than 2-fold in Pcgf5Δ/Δ GMPs relative 
to WT GMPs. (H) ChIP-sequence data of 3xFlag-Pcgf1, 3xFlag-Pcgf5, and H2AK119ub1 
in MEL cells. Venn diagram shows the overlap between Pcgf1 targets, Pcgf5 targets, and 
H2AK119ub1 genes ( 2-fold enrichment of ChIP signals over the input signals at 2.0 kb 
 TSSs) (listed in gene symbol) in MEL cells. 
 
Table 1. Target genes of Pcgf5, Pcgf1 and H2AK119ub1 in MEL cells identified by 
ChIP-Seq. (A). 441 common target genes of Pcgf5 and Pcgf1 with H2AK119ub1 
modification. (B). 53 Pcgf5 target genes with H2AK119ub1 modification, but not bound 
by Pcgf1. 
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441 common target genes of Pcgf5 and Pcgf1 with H2AK119ub1 modification
Gene symbol 3xFlag-Pcgf5/Input (log2)
3xFlag-Pcgf1
/Input (log2)
H2AK119ub1
/Input (log2)
1 Ablim1 1.28473562 1.34389186 1.89949613
2 Acap2 1.05595827 2.73995341 1.13394458
3 Ache 2.01667443 3.16507442 1.04602843
4 Adcy6 1.25500343 2.61053467 1.7905259
5 Aff1 1.46953787 3.51212962 1.24945159
6 Ago1 1.2249089 1.52006918 1.17579153
7 Agpat1 1.07325187 2.01120379 1.26323121
8 Agrn 1.00318165 2.83102786 2.66444802
9 Ak8 1.06656538 1.71776721 1.4525523
10 Alkbh5 1.06236926 2.84575464 1.35638156
11 Amd1 1.26611555 3.33079771 1.25095531
12 Amd2 1.26611555 3.33079771 1.25095531
13 Ankrd33b 1.2143872 3.55959679 1.61349671
14 Ankrd63 1.08089468 3.12477278 2.66829554
15 Anp32b 1.08039608 3.4876461 1.1018013
16 Apoo 1.32790425 1.95637727 2.17093828
17 Apoo-ps 1.26363866 1.93294196 2.12199393
18 Appl2 1.49117299 1.99275892 2.46741651
19 Arhgap21 1.57422989 4.08390851 2.02378297
20 Arhgef12 1.22337547 3.33001808 1.5032094
21 Arid1a 2.15237168 3.67288346 2.51910654
22 Arid1b 1.43097787 4.43146645 1.8038955
23 Arid2 1.63566552 4.42137296 1.18931972
24 Art4 1.58120558 1.4486516 1.2043259
25 Asic4 1.41553693 3.45119297 2.69012399
26 Ate1 1.15232572 1.92319048 1.02375563
27 Atp2b1 1.13721996 3.8399537 1.98708181
28 Atp8b2 1.2233621 2.33188043 1.67122363
29 Atxn1 1.13684536 4.2856634 1.89073725
30 B3glct 1.00288561 2.47426604 1.22980761
31 B3gnt2 1.12061015 3.18155916 1.86921407
32 B4galnt1 1.12861545 3.49545629 1.77134641
33 Bad 1.09468528 2.01600391 1.22248809
34 Bahd1 1.11485775 3.44344155 1.78087324
35 Banp 1.02657633 2.40167715 1.18639757
36 Baz2a 1.05969758 2.49165732 1.08716484
37 BB287469 1.70011037 1.03197804 1.52614754
38 Bcl2 1.2377444 3.4119319 1.87188911
39 Bcl2l11 1.03795056 3.6917661 2.23238641
40 Bcor 1.56853565 4.35159089 2.43726667
41 Brd2 1.4196688 4.30959408 1.6443342
42 Brd3 1.14721261 3.24500659 1.35638842
43 C030037D09Rik 1.08834086 3.68404867 1.41295752
44 C030039L03Rik 1.21432495 2.34661045 1.52627672
45 C330006A16Rik 1.01100742 2.63613258 1.49382983
46 C630043F03Rik 1.33207205 3.9655445 1.55139239
47 Calm1 1.16318393 3.88040954 1.81424614
48 Capn1 1.10115954 1.40092144 1.31330698
49 Cbfa2t3 1.73276644 2.05804313 1.83437677
50 Cbs 1.03860325 1.19065796 1.10940907
51 Cbx4 1.11487754 3.45244989 1.61114736
52 Ccdc63 1.14878484 1.52460785 1.73970691
53 Ccm2 1.00468897 1.87274318 1.08144853
54 Ccno 1.02904216 1.44697481 1.10485685
55 Ccrl2 1.10741079 2.19202997 1.51989435
56 Cd164 1.12202289 3.04131889 1.26321547
57 Cd24a 1.22873314 3.75150155 1.4519765
58 Cdc42ep1 1.38665794 2.983395 2.81764235
59 Cdc42ep4 1.10820885 2.83300159 1.59170735
60 Cebpb 1.25440967 3.61693192 2.17579153
61 Celsr3 1.17070853 1.75577834 1.66376532
62 Cenph 1.53310555 1.32634086 1.10940907
63 Cep55 1.00585934 1.88360374 1.14489697
64 Cited2 1.27710959 3.96201929 1.57872085
65 Clcf1 1.2945051 2.98759087 1.92426682
66 Clcn4-2 1.07595585 2.82845837 1.46739829
67 Clic1 1.22813858 2.19120556 1.48190294
68 Clip2 1.02172061 2.06166475 1.68497071
69 Cmip 1.1018692 3.04338698 1.77136323
70 Cnot6l 1.24195155 3.82390489 1.65183202
71 Cnot8 1.20230318 2.71650311 1.67834744
72 Cntfr 1.06218961 1.46189602 2.03448044
73 Cpeb2 1.32296015 4.59642563 1.86496042
74 Cpsf6 1.00318165 3.31034977 1.22509698
75 Cpt1a 1.36901439 3.4462089 1.95863975
76 Crocc 1.15555504 1.63121506 1.9208246
77 Csk 1.04083405 2.6305985 1.13398821
78 Ctbp2 1.78386009 4.7617021 2.356368
79 Ctcf 1.10115954 2.83978684 1.33794954
80 Cul4a 1.09904796 2.70462805 1.01531282
81 Cuta 1.02169684 1.7110341 1.1687775
82 Cux1 1.10863667 4.11073817 1.73781066
83 Cyb5b 1.41200842 1.58982967 1.13394595
84 D130020L05Rik 1.10820885 2.57963365 1.01533271
85 D1Ertd622e 1.41800944 3.82336275 1.53799676
86 Dcaf5 1.06815834 3.33060255 1.64583292
87 Ddost 1.39314489 1.82314425 1.03947945
88 Ddx3x 1.09670044 2.76440515 1.16365993
89 Depdc1b 1.19386819 2.2018619 1.69077671
90 Dleu2 1.12784254 3.43218394 1.22248809
Gene symbol 3xFlag-Pcgf5/Input (log2)
3xFlag-Pcgf1
/Input (log2)
H2AK119ub1
/Input (log2)
91 Dlx1 1.24034395 3.43959989 1.27292186
92 Dmwd 1.72724366 3.04660357 2.73884939
93 Dnajb14 1.02741427 2.70372483 1.16693737
94 Dnmt3a 1.29587212 3.56991856 2.77698728
95 Dock9 1.03700703 2.65088797 1.49654493
96 Dtnbp1 1.0921623 2.29987861 1.04322053
97 Dus3l 1.47035399 1.95203671 1.18639757
98 E130215H24Rik 1.02630432 2.89703357 1.79595039
99 Eaf1 1.1762339 2.67377273 1.07877301
100 Ece1 1.03926412 2.28416616 1.7093975
101 Eef2k 1.31387517 2.84707535 1.76298905
102 Egr3 1.40611766 3.28289607 2.05296375
103 Elf2 1.40762251 3.9685302 1.2714614
104 Erf 1.25826993 3.29970157 1.98314645
105 Espn 1.1315094 2.61689375 1.86953097
106 Etv5 1.01667443 3.62070111 1.38774602
107 F2r 1.11479373 3.045636 1.23673727
108 Fam134a 1.01236427 2.85430609 1.25135224
109 Fbxo11 1.85731905 3.50419255 1.48677587
110 Fchsd2 1.02172061 2.42055692 1.46739829
111 Fhdc1 1.2127487 3.65712303 2.31436277
112 Fli1 1.45874353 3.01831125 1.86160833
113 Flt3l 1.34285673 1.87212084 1.23673727
114 Fnbp1 1.07421641 2.37989642 1.66121835
115 Foxo3 1.16318393 4.13812755 2.53927193
116 Frmd4a 1.16471486 2.40236724 1.1687775
117 Ftl1 1.0036044 2.60233622 1.68497071
118 Fzd5 1.28473562 3.70592485 1.71573784
119 Fzd7 1.32393578 3.75590175 1.82584016
120 Gabpb1 1.18913483 3.09387894 1.52633498
121 Gadd45g 1.14728212 4.31275932 1.71185121
122 Gapdh 1.10115954 2.37864954 1.61071431
123 Gdf15 1.11485775 1.51653545 1.09693112
124 Gga1 1.05210336 1.82116425 1.22509698
125 Git2 1.22445986 3.11721197 1.62872392
126 Gm13283 1.10503547 2.40679885 1.799994
127 Gm13375 1.21129933 4.03054619 2.1018013
128 Gm15085 1.28551198 1.22514303 1.61982393
129 Gm7854 1.30919433 4.49403699 1.89783746
130 Gnas 1.34229375 3.43072039 1.59170735
131 Gpr137 1.15436947 2.05163021 1.48185204
132 Gpr146 1.02906903 2.87729494 1.69843218
133 Grb2 1.01700834 2.87992622 1.08988734
134 Grsf1 1.10578818 2.74138153 1.72554184
135 Gse1 1.83728182 4.09272536 2.86436391
136 H2afy3 1.07174549 1.40617659 1.23236749
137 H2afz 1.026926 3.17970444 1.13394769
138 H3f3a 1.26687089 3.50517209 1.04602843
139 Hes1 1.56976478 3.99907897 2.02574436
140 Hexim1 1.21918096 2.98435913 1.34044666
141 Hipk2 1.0216742 3.43889939 1.03439448
142 Hist1h1a 1.29843326 2.56274568 1.42341068
143 Hist1h2ao 1.18562204 3.89708805 1.9440222
144 Hist1h2ap 1.18562204 2.31212555 2.9440222
145 Hist1h3a 1.16471486 3.05614437 1.51067318
146 Hist1h4n 1.94786922 3.39457616 1.61948394
147 Hmga1 1.44982028 3.97345883 1.83174467
148 Hmga1-rs1 1.44982028 4.03803308 1.88400328
149 Hnrnpk 1.47738017 3.51919617 1.66671533
150 Hnrnpll 1.20945141 3.4749958 1.33985212
151 Hoxc10 1.09571871 2.4469996 1.12841068
152 Ier2 1.22588327 3.30203663 1.0888609
153 Ifngr2 1.54485903 2.61691328 1.78087324
154 Igf1r 2.09028889 4.67122438 2.28592505
155 Inafm1 1.19455557 2.40236724 1.24528306
156 Ints6 1.55461402 3.23475981 1.12500594
157 Iqce 1.18886004 2.33425797 1.38875494
158 Irf2bp2 1.3660269 4.05163021 1.89398471
159 Irgq 1.49866613 2.65480874 1.99682881
160 Irs2 1.18913483 4.34033988 2.09695348
161 Itpk1 1.31387517 2.51185634 2.11130138
162 Jade1 1.18171702 3.33529451 2.09695348
163 Jade2 1.71613941 3.32146177 1.55429558
164 Josd1 1.12725674 3.01467689 1.21548333
165 Junb 1.20760438 3.82616559 1.70866079
166 Jund 1.00694265 3.42472968 1.09327997
167 Kazald1 1.04083405 3.42102207 1.7188881
168 Kcne3 1.10254344 2.15598199 1.49382983
169 Kdm5b 1.00585934 3.28829011 1.78930119
170 Keap1 1.00169512 2.69266413 1.47601157
171 Kifc1 1.25619346 1.13763924 1.35638842
172 Klf1 1.21223011 2.46666388 1.4906974
173 Klf10 1.61734274 3.65759909 1.81089619
174 Klf13 1.36462611 4.08500916 1.42429605
175 Klf16 1.01178796 2.76827532 2.0807268
176 Klhl17 1.1725219 3.0282395 1.48677587
177 Klhl22 1.14723853 2.89699687 1.59732752
178 Kmt2a 1.65675427 3.49866006 2.00544341
179 Kmt2c 1.3387067 3.78912743 1.0418135
180 Kmt2e 1.18957335 3.22462734 1.02700775
Table 1   
A
Gene symbol 3xFlag-Pcgf5/Input (log2)
3xFlag-Pcgf1
/Input (log2)
H2AK119ub1
/Input (log2)
181 L3mbtl3 1.15436947 3.45763675 1.06684201
182 Lemd3 1.05128964 3.17374368 1.70573431
183 Lgr5 1.7301972 1.70646506 3.72424161
184 Lincpint 1.02169319 3.11747813 1.4323351
185 Lmnb1 1.0216742 3.57858164 1.33867973
186 Lpcat4 1.44522637 2.6305985 1.37651228
187 Lphn1 1.22813858 3.1942393 1.87901021
188 Lrrc59 1.01182513 3.20825101 1.14613045
189 Lrrc8d 1.12391929 3.60131477 1.69338472
190 Ltk 1.50718346 2.83702821 1.25095531
191 Lyl1 1.48660137 2.2280565 2.41477982
192 Maml3 1.09294514 3.88279364 1.20825217
193 Man1a2 1.01663691 3.326692 1.00101091
194 Man2a1 1.10367084 3.39854107 1.68609291
195 Mapk14 1.00235054 3.47257062 1.63547242
196 Marcksl1 1.02170305 2.75065299 2.28929058
197 Mars2 1.02172938 2.65986402 1.42845936
198 Maz 1.33298861 3.32475266 2.00646813
199 Mb21d1 1.24229853 3.03407809 1.71308982
200 Mbnl1 1.11085287 2.44182904 1.54273921
201 Mbp 1.06595583 2.36152036 1.35636956
202 Med13l 1.25374485 3.93711618 1.8969468
203 Mesdc1 1.12861545 3.70812915 1.94131422
204 Mettl6 1.18216602 2.71336332 1.04322053
205 Mex3b 1.10032246 4.25390447 2.11130138
206 Mfsd11 1.24034395 3.02591202 1.07347244
207 Mfsd2b 1.09971784 1.74331736 1.56933297
208 Micall2 1.32126993 1.93610885 2.04183242
209 Mid1ip1 1.12944262 3.02110727 1.28680826
210 Mief2 1.01100742 2.46604948 1.21193482
211 Mir5135 1.10946878 3.03054619 2.18353196
212 Mir5620 1.04560875 2.8005579 1.67000563
213 Mir6236 2.13072245 1.97276604 1.07089986
214 Mir7687 1.43228905 3.60971353 2.70918912
215 Mir7b 1.31651903 1.1981645 1.40879585
216 Mir8105 1.08039608 2.49010807 1.3742322
217 Mllt3 1.15436947 3.36853701 1.57354924
218 Mnt 1.18518958 3.18041107 1.52635255
219 Mpzl2 1.6173882 1.75065299 1.73781066
220 Mrpl12 1.05595827 1.742471 1.3265633
221 Msi2 1.26538494 3.5380497 1.3563391
222 Mvb12b 1.00468897 2.24153967 1.31687365
223 Myb 1.01700834 3.54073347 1.35635012
224 Myc 1.8055739 3.68025647 1.4906974
225 Myh10 1.24871938 2.99254639 1.67830245
226 Mylip 1.07635862 3.47565109 1.16109646
227 Naf1 1.77513579 2.36758703 1.19591495
228 Nckap1 1.62380601 3.90076994 1.21016446
229 Ncor2 1.21171651 2.89095145 1.94127141
230 Ndst2 1.31760009 2.20411228 1.49382983
231 Nfat5 1.20678601 2.64698691 1.14293835
232 Nfatc4 1.00318165 2.08970411 2.07694885
233 Nfe2l2 1.23416471 3.41933315 1.01928975
234 Nfia 1.08039608 3.51000282 2.11637713
235 Noc2l 1.09468528 3.01228549 1.42429605
236 Nol4l 1.3350277 3.98254255 2.67824247
237 Nop56 1.05345294 1.8374101 1.05052358
238 Npas4 2.69981446 2.91319977 2.09327997
239 Nr2f1 1.16219458 3.81664945 1.11127405
240 Nr2f6 1.04085847 2.45072133 1.40215994
241 Nt5c2 1.20120873 2.42710079 1.72339681
242 Oaf 1.44762306 2.85646291 1.39239031
243 Orai3 1.04936713 2.17950264 1.35632832
244 Ott 1.28551198 1.22514303 1.61982393
245 Oxsr1 1.14228116 2.4267381 1.28680826
246 Pabpc4 1.01392029 1.62451772 1.13394595
247 Paip1 1.14723853 3.7319671 1.57459059
248 Paqr7 1.10311847 2.41966003 1.60251981
249 Parl 1.12511329 1.38752973 1.11280489
250 Pawr 1.12784254 3.36649923 1.356368
251 Pax6 1.54485903 3.59049332 1.86537628
252 Pbx2 1.05210336 2.48760679 1.50995893
253 Pbx3 1.1851903 3.12717463 1.62872392
254 Pcid2 1.10414503 2.66321653 1.05052358
255 Pde3b 1.026926 3.78903787 1.73189065
256 Pde4a 1.15808239 3.0251245 1.72790085
257 Pfn1 1.33417137 3.57823336 1.05677277
258 Pgls 1.3928401 2.47772686 1.16756223
259 Pgpep1 1.14908432 1.96799138 1.76727161
260 Phf12 1.00694265 2.82692705 1.0608406
261 Phf13 1.42026503 3.72255783 2.80886003
262 Phf21a 1.25374485 3.33749935 1.10483342
263 Pim3 1.03857097 3.39881685 1.87419582
264 Pip4k2a 1.20380964 3.0857091 1.25323526
265 Pkd1l2 1.62180069 1.72075317 2.22310676
266 Plec 1.06907329 2.45489297 2.21963306
267 Plekhh3 1.54230268 3.06290648 2.83443932
268 Plxnc1 1.3350277 3.92025936 2.50200566
269 Pnpla7 1.14721261 2.04873028 1.5262248
270 Poldip3 1.19216926 2.81692591 1.46496092
Gene symbol 3xFlag-Pcgf5/Input (log2)
3xFlag-Pcgf1
/Input (log2)
H2AK119ub1
/Input (log2)
271 Pou4f1 1.12432504 3.52511509 1.19717845
272 Ppargc1b 1.3747085 3.16179999 1.27837531
273 Ppp1r3f 1.04218674 2.16233195 1.11821096
274 Ppp1r3fos 1.00792152 2.38732477 1.24472047
275 Prkab1 1.26611555 2.91223053 1.3742322
276 Psat1 1.31870136 2.65326553 1.61940397
277 Psma7 1.31515971 2.64516621 1.4525523
278 Psmb3 1.00694265 2.62378418 1.45304313
279 Ptch1 1.62422662 4.14297509 2.08988734
280 Ptma 1.60671842 3.82239101 1.76298905
281 Ptprs 1.43679359 2.59809821 2.56826763
282 Ptpru 1.12202289 3.77235272 2.16368335
283 Pxk 1.28474405 2.34245404 1.19131668
284 Rai1 1.55782731 3.38158693 1.53322108
285 Ranbp1 1.1378923 2.58399368 1.24085716
286 Rap1b 1.00585934 2.95640576 1.48196741
287 Rarg 1.06540646 3.4991115 2.30187794
288 Rasa3 1.50717599 2.71314376 1.03439448
289 Rasal1 1.26812006 2.09219854 2.22146021
290 Rbbp4 1.07417614 2.35605442 1.22861029
291 Rcor1 1.36135557 3.61694464 1.80805339
292 Rdm1 1.17368238 2.27902741 1.11541758
293 Reep5 1.17847747 2.47254231 1.19811303
294 Rhob 1.10920714 3.72442807 2.13394595
295 Rhoq 1.03587187 2.98793812 1.80697098
296 Rmi1 1.55461402 3.46030936 1.71251307
297 Rnasek 1.03587187 2.48415629 1.1637096
298 Rnaset2b 1.15931032 1.96708416 2.52631155
299 Rnpepl1 1.03986049 3.03837961 2.17450696
300 Rnu12 1.13907775 2.81703891 1.3090222
301 Rogdi 1.16379105 1.80960456 1.76378811
302 Rpl29 1.10503547 1.09341502 1.10485685
303 Rpl31 1.06595583 1.99718831 1.11532068
304 Rsrp1 1.02657633 3.49220133 1.29557131
305 Rtbdn 1.63510721 2.35474074 2.18236636
306 Runx1 1.10414503 1.51282854 1.05551441
307 Rxrb 1.18131261 2.31332729 1.81424614
308 S1pr1 2.16446841 2.69024906 2.27386765
309 Samd11 1.61237677 2.60312332 1.94134905
310 Sap30 1.06595583 2.85395467 1.15471703
311 Schip1 1.08089468 3.7079747 1.97449473
312 Scrib 1.13370566 1.8095828 1.29747557
313 Scrt1 2.30095624 3.28404205 2.29423615
314 Senp6 1.30550752 3.51967879 1.60568032
315 Serf2 1.18528358 2.78533164 1.22858296
316 Setd1a 1.02172061 2.19951597 1.25950466
317 Setd1b 1.12861545 2.930298 1.51989435
318 Sgms1 1.09754735 3.33529451 2.26712678
319 Sgsh 1.43062848 1.84985613 2.8054126
320 Shb 1.37784748 3.59174237 2.18525771
321 Shox2 1.11481905 3.6763286 1.16371129
322 Siah2 1.03535812 3.58011361 1.67340462
323 Six2 1.18528358 3.10549833 1.65589466
324 Six5 1.03795056 3.18999515 1.75372634
325 Ski 1.30311842 3.6543072 2.52630561
326 Skil 1.45756405 3.59293073 1.67824247
327 Slc14a1 1.1880674 1.88758862 1.24472047
328 Slc16a13 1.17184765 1.83813373 1.74630021
329 Slc16a6 1.0459464 3.34245404 1.47664512
330 Slc26a11 1.41200842 1.82285303 2.76934857
331 Slc35b2 1.2205981 2.03605269 1.25167783
332 Slc38a7 1.24722893 1.15951021 1.90476654
333 Slc39a7 1.27532446 2.36416538 1.77577759
334 Slc48a1 1.15547357 2.74304904 1.05197966
335 Smad7 1.22652898 4.2932214 1.83594763
336 Smarcc2 1.0009544 2.48161862 1.25323526
337 Smarcd2 1.18853026 2.42294724 1.28137358
338 Smek1 1.12162841 2.45431839 1.1438524
339 Sms 1.09062404 2.76732188 1.45941465
340 Snca 1.21432495 1.75186888 1.025722
341 Snora16a 1.07174549 1.90387556 1.55665223
342 Snord110 1.41971602 1.8465757 1.28923332
343 Socs2 1.05735574 3.78533164 1.97881187
344 Spred1 1.06907329 3.85299727 1.67824247
345 Spred2 1.10115954 3.36287787 1.43882593
346 Sptbn4 1.52701327 1.95121126 1.7245205
347 Srsf1 1.31870136 3.15493159 1.17265174
348 Ss18l1 1.31515971 2.64516621 1.46924114
349 Ssbp4 1.12092624 2.90716023 1.73781066
350 St3gal4 1.10695505 2.35780081 1.61939897
351 Stk40 1.55125351 2.56802097 1.6537769
352 Stt3b 1.05998875 3.35016759 1.0608406
353 Stx2 1.14340174 2.00686868 1.28137358
354 Tal1 1.72676124 3.69838802 1.65589466
355 Tfap4 1.69981446 3.09384779 1.45609
356 Tfe3 1.13721996 2.04520285 1.78927881
357 Tfeb 1.02784986 2.61383078 1.66571669
358 Tfr2 1.53628728 1.72707943 2.01008071
359 Tgif1 1.60491319 3.34281463 1.64759457
360 Tgif2 1.16632605 2.83506895 2.06686544
Gene symbol 3xFlag-Pcgf5/Input (log2)
3xFlag-Pcgf1
/Input (log2)
H2AK119ub1
/Input (log2)
361 Them6 1.10695505 2.82875923 1.14293835
362 Tiparp 1.07258104 4.06995263 1.30084089
363 Tle1 1.2042609 3.96941594 1.61941596
364 Tmem14c 1.3587631 2.02886325 1.14985593
365 Tmem206 1.03587187 1.99673916 1.61071431
366 Tmem88 1.03689447 1.32145413 1.3563391
367 Tnk2 1.03323296 3.16439353 1.83941155
368 Tnpo2 1.47966249 2.38773423 1.45587404
369 Tnrc6c 1.1378923 4.29116874 2.25097767
370 Trim16 1.03795056 2.24740604 1.22248809
371 Trim8 1.53475679 3.98356322 1.4465302
372 Trmt2a 1.04770912 2.57843076 1.26888863
373 Trp53 1.32273198 2.45431839 1.13394595
374 Tsc22d2 1.3093064 4.11313526 1.36811428
375 Tsc22d3 1.03238627 3.47515041 1.2204258
376 Tsc22d4 1.12861545 2.79011067 1.42194178
377 Tshz1 1.14411776 4.28570611 2.03755824
378 Tspan32 1.98273489 1.73662838 1.4861253
379 Ttyh2 1.08089468 2.80175511 1.57872085
380 Tyro3 1.21720727 2.65619181 1.46428644
381 Ubald1 1.14344857 3.12084143 1.63475097
382 Ubr3 1.08678532 2.76203476 1.30185902
383 Ubr5 1.07829063 2.54373984 1.2042967
384 Ubtf 1.46534275 4.3747573 1.97783505
385 Unkl 1.1148678 2.27833575 1.08571266
386 Usf2 1.01667443 2.42731858 1.41520806
387 Usp49 1.06540646 1.82974433 1.13398821
388 Usp7 1.05932941 3.45072133 1.94128407
389 Vars 1.47356136 2.67117531 1.69349176
390 Vdac1 1.24340676 3.05617685 1.73189065
391 Vegfa 1.16794346 3.62788109 1.8344267
392 Vezf1 1.15668789 2.75209969 1.60251981
393 Vgf 1.03418085 2.53688765 2.74574742
394 Vim 1.56229797 3.24421613 1.70783166
395 Vstm2l 2.10695505 2.34245404 1.23673727
396 Wdr26 1.02784986 2.75709695 1.35638156
397 Wipf2 1.29699449 1.96432255 1.08988734
398 Wnt5b 1.23865965 1.23103206 2.14221853
399 Wrap53 1.01700834 2.10650978 1.42940688
400 Xkr7 1.09062404 1.22459207 1.42284159
401 Xylt1 1.00908349 2.99089645 1.65589466
402 Yipf6 1.13271291 2.66041802 1.49396797
403 Ywhaz 1.41596644 3.41138043 1.39484427
404 Yy1 1.21437235 3.42915343 1.69344596
405 Zadh2 1.10367084 3.70902919 1.67828446
406 Zbtb25 1.19806824 3.85460585 1.61941596
407 Zbtb7a 1.07830799 3.82996579 1.32466941
408 Zbtb8os 1.15746458 2.35093941 1.17836549
409 Zc3hav1 1.00065072 3.45343431 1.87318946
410 Zdhhc17 1.08039608 3.31481394 1.53192304
411 Zdhhc2 1.18040841 2.71287998 1.05383104
412 Zeb2 1.24034395 3.91624117 1.57869743
413 Zfand5 1.03587187 3.58867702 1.2699241
414 Zfp36l1 1.17936516 3.80608438 1.49382983
415 Zfp36l2 1.35035291 4.84399504 2.37945841
416 Zfp609 1.04218674 2.59736952 1.3774425
417 Zfp703 1.09102625 3.86959618 1.35636221
418 Zfp768 1.07177847 1.66197808 1.10260439
419 Zfp821 1.27487142 2.6997772 1.4906974
420 Zfpm1 1.41437934 2.94593843 2.15471703
421 Zic5 1.32126993 3.27391439 1.21888719
422 Zmiz1 1.65754354 4.76262572 2.09327997
423 Zmym3 1.14736814 1.92154248 1.03435348
424 Zmynd11 1.62422662 3.68962453 1.29493094
425 Znrf1 1.02741427 2.47701504 1.32354066
426 8-Sep 1.15727929 2.80958489 1.40700722
427 0610010K14Rik 1.03587187 2.87257165 1.84616878
428 2410004B18Rik 1.11485775 2.37107734 2.03695161
429 2610005L07Rik 2.10194731 2.2766976 1.26330994
430 2700046G09Rik 1.29381403 3.46666532 1.87094753
431 4930426L09Rik 1.26687089 2.97005506 1.23236749
432 4930581F22Rik 1.00318165 2.33079771 1.58226983
433 4931440J10Rik 1.46009803 3.21732878 1.25095531
434 4931440P22Rik 1.05649024 3.89606313 1.10991697
435 5430405H02Rik 1.02841506 3.21646119 1.89241605
436 5730420D15Rik 1.01726781 3.8726275 1.35631437
437 5830417I10Rik 1.59288439 1.75291063 1.06696582
438 6530402F18Rik 1.08977315 3.73353056 1.99646205
439 9530052E02Rik 1.16632605 4.20793972 2.32723923
440 9630033F20Rik 1.26687089 1.27088409 2.18639757
441 A530013C23Rik 1.17847747 3.44784394 2.04563319
B 53 Pcgf5 target genes with H2AK119ub1 modification, but not bound by Pcgf1
Gene symbol 3xFlag-Pcgf5/Input (log2)
H2AK119ub1
/Input (log2)
1 Apba2 1.380618855 1.166326048
2 Ar 1.356281576 1.056490239
3 Ascl2 1.299763145 1.534756795
4 Bhlhe41 1.175791527 1.163183929
5 Cda 1.278367461 1.3350277
6 Crb2 1.481902938 1.13684536
7 Dlk1 1.558913326 1.309306398
8 Dner 1.267558406 1.144117756
9 Dpysl3 1.240927595 1.078307993
10 Epo 1.157045168 1.092945136
11 G530011O06Rik 1.467325403 1.635665522
12 Gm11236 1.357798051 1.449820276
13 Gm11237 1.357798051 1.072581041
14 Gm1140 1.356537505 1.21129933
15 Gm14692 1.356537505 1.569764781
16 Gm15133 1.357798051 2.090288885
17 Gm1604b 1.204786433 1.309194333
18 Helt 1.407007218 1.137219963
19 Hhex 1.408795851 1.017267808
20 Hspb1 1.672785994 1.624226618
21 Idi2 1.093279969 1.3350277
22 Il3ra 1.074533799 1.204260903
23 Ipw 1.482182937 1.568535652
24 Kcna6 1.503209399 1.100322461
25 Lhx1 1.249451586 1.091026248
26 Lhx1os 1.182296492 1.623806012
27 LOC100862015 1.357798051 1.366026899
28 LOC101055863 1.357798051 1.226528977
29 LOC102636514 1.672785994 1.240343954
30 Mir6538 1.414092412 1.207604376
31 Mir6988 1.55085067 1.837281816
32 Mybpc3 1.963984652 1.198068236
33 Nhlrc4 2.263204971 1.277109591
34 Nkd1 1.340922655 1.069073291
35 Nxph1 1.521024691 1.332072053
36 Ophn1 1.69736165 1.322960154
37 Pappa 1.146130449 1.449820276
38 Pirb 2.678662407 1.137892299
39 Podn 1.83594763 1.185622041
40 Prkcdbp 1.412957516 1.465342748
41 Psme1 1.005443411 1.574229888
42 Pvrl4 1.372443476 1.25374485
43 Rpp25 2.178365489 1.364626113
44 Scgb1b29 1.357798051 1.350352913
45 Slc4a1 2.921477549 1.657543542
46 Snord116 2.94781378 1.419668797
47 Snord116l1 2.94781378 1.147282122
48 Snord116l2 2.94781378 1.189134832
49 Sytl3 1.760754028 1.430977868
50 Tmem86b 1.655035072 1.407622508
51 Trim12a 1.357798051 1.783860089
52 Tspo2 1.376512284 1.108636675
53 4931431F19Rik 1.115320683 1.163183929
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